Ficha del valor · trimestre archivado
ENTA
Enanta Pharmaceuticals, Inc. · Healthcare · Biotechnology
16Tenedores rastreados
+1Δ titulares
7.96MAcciones mantenidas
$95.31MValor declarado
+2Nuevas posiciones
−1Cierres
Señales de momentum (gestores comparables):
amplitud de titulares +6.7% ·
flujo de acciones -12.3% ·
nuevas posiciones netas +6.2%
— fórmula
Fragmentación de la titularidad — más titulares, participación agregada menor
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2025
Participación a lo largo del tiempo
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 56 | -3 | 10.74M | $156.55M | +2 | −5 |
| Q1 2026 | 62 | -2 | 14.86M | $187.69M | +5 | −7 |
| Q4 2025 | 64 | +3 | 16.10M | $253.79M | +3 | — |
| Q3 2025 | 16 | +1 | 7.96M | $95.31M | +2 | −1 |
| Q2 2025 | 12 | 0 | 8.38M | $63.38M | — | — |
| Q1 2025 | 9 | -2 | 4.49M | $24.81M | — | −2 |
| Q4 2024 | 11 | -1 | 4.05M | $23.26M | — | −1 |
| Q3 2024 | 11 | +2 | 4.15M | $43.00M | +2 | — |
| Q2 2024 | 9 | — | 3.87M | $50.19M | — | — |
Quién lo tiene en cartera · Q3 2025
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 1.94M | -1.9% | $23.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasivo) | 1.94M | -1.9% | $23.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasivo) | 1.94M | -1.9% | $23.21M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasivo) | 1.83M | -0.8% | $21.94M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 948.08K | -35.0% | $11.35M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Geode Capital Management ✦ (pasivo) | 493.19K | +1.5% | $5.90M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Geode Capital Management ✦ (pasivo) | 493.19K | +1.5% | $5.90M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 16 | Renaissance Technologies ✦ | 479.60K | +2.1% | $5.74M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (pasivo) | 471.99K | +0.4% | $5.65M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Point72 Asset Management ✦ | 300.00K | Nuevo | $3.59M | 0.0% | New | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 282.63K | — | $3.38M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Marshall Wace ✦ | 275.39K | -67.9% | $3.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 27 | Marshall Wace ✦ | 275.39K | -67.9% | $3.30M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 247.63K | — | $2.96M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 226.84K | -42.7% | $2.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 39 | D. E. Shaw & Co. ✦ | 225.74K | -20.0% | $2.70M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 40 | Goldman Sachs Group ✦ | 166.43K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | Goldman Sachs Group ✦ | 166.43K | — | $1.99M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | Two Sigma Investments ✦ | 60.72K | -22.6% | $726,842 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 43 | T. Rowe Price ✦ | 10.15K | Nuevo | $122,000 | 0.0% | New | 1 | SEC ↗ |
| 44 | Fidelity (FMR) ✦ | 1.78K | -0.3% | $21,363 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 1.78K | -0.3% | $21,363 | 0.0% | ▼ Trim | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Point72 Asset Management | $3.59M | 0.0% |
| T. Rowe Price | $122,000 | 0.0% |
Posición cerrada
| Citadel Advisors | $447,129 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 131 tenedores, 26.72M acciones, $290.62M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Frecuentemente cotituladas
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Aug 14
SC 13G/A — FARALLON CAPITAL MANAGEMENT, L.L.C.
Aug 14
SC 13G/A — Deep Track Capital, LP
Procedencia: Participación a partir de posiciones en acciones ordinarias de 13F procesadas (universo rastreado, conjuntos comparables para cambios); filas de iniciados de los Formularios 3/4/5; participaciones de los Schedules 13D/13G; cada filing enlaza con su original en SEC EDGAR.
Período de reporte: Q3 2025 ·
Metodología ·
Obtener esto a través de la API